The information on this website is intended for healthcare professionals only and is provided solely for the purpose of scientific exchange. By accessing this website you accept this legal disclaimer and you expressly confirm your status as a healthcare professional.
This website is not country specific and may therefore contain information that is not applicable to your country. The website is not intended to provide medical advice and/or treatment guidance. Therefore, before prescribing any product, always refer to information approved by regulatory authorities in your country such as the prescribing information and/or the Summary of Product Characteristics. Novo Nordisk accepts no liability for the accuracy, completeness or use of information on this website, and disclaims any liability to update the information contained on this website.
Giovanni Frisoni was educated in Brescia and Parma, Italy. In 1986, he obtained a degree cum laude in medicine and surgery, and in 1990, a specialization in neurology. Founder, with other doctors, of the Alzheimer's Unit at Brescia Hospital - which has since become the National Center for Alzheimer's Disease (IRCCS) Fatebenefratelli - there he was Head of the Psychogeriatrics Department and responsible for the Alzheimer Day Hospital.
Giovanni Frisoni created in 1999, within the IRCCS, the laboratory of epidemiology in neuroimaging and telemedicine (LENITEM) and the Unit of translational care; he was also, from 2013 to 2015, the Scientific Director of the IRCCS. Principal researcher of several projects at European and international level, he has also held technical and scientific positions in numerous research institutes.
His work focuses on the translation into clinical practice of fundamental discoveries in neuroimaging. He was appointed Full Professor in the Department of Psychiatry of the Faculty of Medicine in September 2013.